Beta-Endorphin Controls the Pleasure of Eating, Not Just How Much You Eat
Beta-endorphin from POMC neurons modulated the appetitive (wanting/seeking) phase of feeding behavior in a state-dependent manner, separate from consummatory eating, linking the opioid system to food reward rather than just hunger.
Quick Facts
What This Study Found
POMC-derived beta-endorphin selectively modulated the appetitive (wanting/seeking) phase of feeding behavior in a deprivation-state-dependent manner, separating opioid reward from hunger-driven consumption.
Key Numbers
How They Did This
Animal study using POMC-deficient mice (beta-endorphin lacking). Appetitive (food seeking) and consummatory (eating) behaviors measured separately under different deprivation states.
Why This Research Matters
If opioids control food wanting (reward/pleasure) rather than hunger, opioid-targeted drugs could treat binge eating and food addiction without affecting normal hunger-driven eating.
The Bigger Picture
Food addiction and binge eating involve the reward system, not just hunger. Beta-endorphin's role in food wanting (not just eating) connects these disorders to the opioid system — the same system involved in drug addiction.
What This Study Doesn't Tell Us
POMC-deficient mice lack multiple peptides (alpha-MSH, ACTH) besides beta-endorphin. The specific contribution of beta-endorphin versus other POMC products is difficult to isolate.
Questions This Raises
- ?Could opioid antagonists (naltrexone) treat binge eating by reducing food wanting?
- ?Does the state-dependent effect explain why opioid reward varies with hunger?
- ?Is food addiction a specific opioid system disorder?
Trust & Context
- Key Stat:
- Wanting vs eating Beta-endorphin controlled food WANTING (reward/seeking) separately from food EATING (consumption) — the opioid system drives pleasure, not hunger
- Evidence Grade:
- Preliminary animal evidence using a genetic model to dissociate appetitive from consummatory feeding behaviors.
- Study Age:
- Published in 2003. The opioid-food reward connection has been further characterized, supporting naltrexone use in binge eating disorder treatment.
- Original Title:
- State-dependent modulation of feeding behavior by proopiomelanocortin-derived beta-endorphin.
- Published In:
- Annals of the New York Academy of Sciences, 994, 192-201 (2003)
- Authors:
- Low, Malcolm J(2), Hayward, Michael D(2), Appleyard, Suzanne M(2), Rubinstein, Marcelo
- Database ID:
- RPEP-00844
Evidence Hierarchy
Tests effects in animals (usually mice or rats), not humans.
What do these levels mean? →Frequently Asked Questions
Why do people binge eat?
The opioid system — specifically beta-endorphin — controls the WANTING and pleasure of food, separate from actual hunger. When this system is overactive, people seek food for its rewarding properties, not because they're hungry.
Could blocking opioids help?
Yes — naltrexone (an opioid blocker) is FDA-approved for binge eating disorder. By reducing the opioid-driven food reward signal, it helps people stop seeking food for pleasure rather than nutrition.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-00844APA
Low, Malcolm J; Hayward, Michael D; Appleyard, Suzanne M; Rubinstein, Marcelo. (2003). State-dependent modulation of feeding behavior by proopiomelanocortin-derived beta-endorphin.. Annals of the New York Academy of Sciences, 994, 192-201.
MLA
Low, Malcolm J, et al. "State-dependent modulation of feeding behavior by proopiomelanocortin-derived beta-endorphin.." Annals of the New York Academy of Sciences, 2003.
RethinkPeptides
RethinkPeptides Research Database. "State-dependent modulation of feeding behavior by proopiomel..." RPEP-00844. Retrieved from https://rethinkpeptides.com/research/low-2003-statedependent-modulation-of-feeding
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.